A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers

Clinical trial NCT05383170 · COMPLETED

Trial details

NCT number: NCT05383170
Sponsor: Cytovation AS
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Head and Neck Squamous Cell Carcinoma Advanced Breast Cancer Advanced Melanoma

Start date: 2023-03-21
Primary completion: 2024-09-23
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.